NASDAQ : MEDP
Medpace Holdings, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 652.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 18.24B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 18.04B |
| Enterprise Value | 17.51B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 21, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 27.97M |
| Shares Outstanding | 27.97M |
| Shares Change (YoY) | -5.07% |
| Shares Change (QoQ) | -0.64% |
| Owned by Insiders (%) | 18.67% |
| Owned by Institutions (%) | 88.78% |
| Float | 22.73M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 35.77 |
| Forward PE | 33.58 |
| PS Ratio | 6.43 |
| Forward PS | 6.17 |
| PB Ratio | 31.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 27.32 |
| P/OCF Ratio | 25.22 |
| PEG Ratio | 2.38 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 34.19 |
| EV / Sales | 6.24 |
| EV / EBITDA | 27.90 |
| EV / EBIT | 29.16 |
| EV / FCF | 26.52 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.83 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | 0.26 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 117.88% |
| Return on Assets (ROA) | 18.71% |
| Return on Invested Capital (ROIC) | 793.61% |
| Return on Capital Employed (ROCE) | 75.28% |
| Weighted Average Cost of Capital (WACC) | 10.25% |
| Revenue Per Employee | $430,058 |
| Profits Per Employee | $78,458 |
| Employee Count | 6,600 |
| Asset Turnover | 1.40 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 109.17M |
| Effective Tax Rate | 17.41% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +10.88% |
| 50-Day Moving Average | 619.68 |
| 200-Day Moving Average | 529.53 |
| Relative Strength Index (RSI) | 53.38 |
| Average Volume (20 Days) | 317,815 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.61M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 5.76% |
| Short % of Float | 7.09% |
| Short Ratio (days to cover) | 6.09 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.84B |
| Gross Profit | 2.05B |
| Operating Income | 607.14M |
| Pretax Income | 626.99M |
| Net Income | 517.83M |
| EBITDA | 634.46M |
| EBIT | 607.14M |
| Earnings Per Share (EPS) | $18.03 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 705.32M |
| Total Debt | 171.46M |
| Net Cash | 533.86M |
| Net Cash Per Share | $19.09 |
| Equity (Book Value) | 584.94M |
| Book Value Per Share | 20.92 |
| Working Capital | -251.10M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 723.05M |
| Capital Expenditures | -55.42M |
| Depreciation & Amortization | 27.33M |
| Net Borrowing | n/a |
| Free Cash Flow | 667.63M |
| FCF Per Share | $23.87 |
Margins
| Measure | Value |
|---|
| Gross Margin | 72.24% |
| Operating Margin | 21.39% |
| Pretax Margin | 22.09% |
| Profit Margin | 18.24% |
| EBITDA Margin | 22.35% |
| EBIT Margin | 21.39% |
| FCF Margin | 23.52% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 5.07% |
| Shareholder Yield | 5.07% |
| Earnings Yield | 2.80% |
| FCF Yield | 3.66% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $651.31 |
| Price Target Difference | 0.99% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 9.02% |
| EPS Growth Forecast (3Y) | 12.67% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 7 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |